Truncal fat mass as a contributor to inflammation in end-stage renal disease

175Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: An activated inflammatory response is a common feature of end-stage renal disease (ESRD) and predicts outcome. Adipose tissue is an endocrine organ that may contribute to an inflammatory burden by secreting adipocytokines such as interleukin 6 (IL-6). Objective: The objective was to relate plasma concentrations of IL-6 in ESRD patients to body composition, regional fat mass distribution, and blood lipid profiles. Design: One hundred ninety-seven ESRD patients (123 men;x- ± SE age: 52 ± 1 y) were evaluated shortly before dialysis started. Lean body mass and truncal and nontruncal fat mass were estimated by dual-energy X-ray absorptiometry. Nutritional status was evaluated on the basis of subjective global assessment and handgrip strength. Inflammatory biomarker and blood lipid concentrations were also evaluated. Results: Median IL-6 (8.5 compared with 4.5 pg/mL; P < 0.001) concentrations were significantly greater in malnourished than in well-nourished patients. Moreover, negative correlations were observed between IL-6 and serum creatinine (ρ = -0.19, P < 0.01), handgrip strength (ρ = -0.24, P < 0.001), and serum albumin (ρ = -0.34, P < 0.001). A significantly higher truncal fat mass (12.8 ± 0.7 compared with 10.5 ± 0.4 kg; P < 0.005) was observed in ESRD patients with inflammation (C-reactive protein ≥ 10 mg/L). Inverse correlations were observed between plasma IL-6 and HDL cholesterol (ρ = -0.16, P < 0.05) and apolipoprotein A (ρ = -0.23, P < 0.001). Conclusions: Plausible relations exist between inflammatory biomarkers, such as IL-6 and high-sensitivity C-reactive protein, and regional fat distribution in ESRD patients. Moreover, the strong inverse relations between HDL cholesterol and apolipoprotein A and biomarkers of inflammation suggest that the chronic inflammatory response observed in ESRD patients is an important contributor to the atherogenic lipoprotein profile in uremia. © 2004 American Society for Clinical Nutrition.

Cite

CITATION STYLE

APA

Axelsson, J., Qureshi, A. R., Suliman, M. E., Honda, H., Pecoits-Filho, R., Heimbürger, O., … Stenvinkel, P. (2004). Truncal fat mass as a contributor to inflammation in end-stage renal disease. American Journal of Clinical Nutrition, 80(5), 1222–1229. https://doi.org/10.1093/ajcn/80.5.1222

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free